Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy)

被引:0
作者
Consonni, Dario [1 ]
Lombardi, Andrea [2 ,3 ]
Mangioni, Davide [2 ,3 ]
Bono, Patrizia [4 ]
Oggioni, Massimo [4 ]
Renteria, Sara Uceda [4 ]
Valzano, Antonia [4 ]
Bordini, Lorenzo [5 ]
Nava, Carlo Domenico [5 ]
Tiwana, Navpreet [6 ]
Silverj, Flaminia Gentiloni [6 ]
Castaldi, Silvana [7 ,8 ]
Rognoni, Magda [9 ]
D'Oro, Luca Cavalieri [9 ]
Carugno, Michele [1 ,10 ]
Luisetti, Giacomo [11 ]
Riboldi, Luciano [5 ]
Ceriotti, Ferruccio [4 ]
Bandera, Alessandra [2 ,3 ]
Gori, Andrea [2 ,3 ,12 ]
Pesatori, Angela Cecilia [1 ,10 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policli, Epidemiol Unit, Milan, Italy
[2] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Infect Dis Unit, Milan, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Clin Lab, Milan, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policli, Occupat Hlth Unit, Milan, Italy
[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Med Direct, Milan, Italy
[7] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
[8] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Qual Unit, Milan, Italy
[9] Agcy Hlth Protect Brianza, Epidemiol Unit, Monza, Italy
[10] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[11] Univ Milano Bicocca, Sch Stat, Milan, Italy
[12] Univ Milan, Ctr Multidisciplinary Res Hlth Sci MACH, Milan, Italy
来源
EPIDEMIOLOGIA & PREVENZIONE | 2022年 / 46卷 / 04期
关键词
COVID-19; SARS-CoV-2; vaccination; healthcare workers; SARS-COV-2; INFECTION; MULTICENTER; ENGLAND;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES: to evaluate immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers (HCWs). DESIGN: cohort study. SETTING AND PARTICIPANTS: in a hospital in Milan (Lombardy Region, Northern Italy) HCWs without ("negative cohort") and with ("positive cohort") history of SARS-CoV-2 infection or elevated serum antibody before the vaccination campaign (27.12.2020) were included. Data collection and follow-up covered the period 27.12.2020-13.05.2022. MAIN OUTCOMES MEASURES: 1. serum anti-spike-1 (anti-S1) antibody levels after vaccination; 2. vaccine effectiveness (VE) against SARS-CoV-2 infections (either symptomatic or not) in the negative cohort. Data on infections were extracted from multiple sources (laboratory, accident reports, questionnaires). Vaccination was treated as a time-dependent variable. Using unvaccinated person-time as reference, hazard ratios (HR) of infections and 95% confidence intervals (95%CI) were calculated with a Cox regression model adjusted for gender, age, and occupation. VE was calculated as (1 - HR)x100. RESULTS: 5,596 HCWs were included, 4,771 in the negative and 825 in the positive cohort. In both cohorts, serum anti-S1 antibodies were high one months after the second dose, halved after six months, and returned to high levels after the third dose. In the negative cohort, 1,401 SARSCoV-2 infections were identified. VE was 70% (95%CI 5480; 46 infected) in the first four months after the second dose and later declined to 16% (95%CI 0-43; 97 infected). After the third dose, VE increased to 57% (95%CI 35-71; 61 infected) in the first month but rapidly declined over time, particularly after three months (24% in the fourth month and 1% afterwards). The number of infections avoided by vaccination was estimated to be 643 (95%CI 236-1,237). CONCLUSIONS: in spite of rapidly declining effectiveness, vaccination helped to avoid several hundred infections in the considered hospital.
引用
收藏
页码:250 / 258
页数:9
相关论文
共 42 条
[1]   Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar [J].
Abu-Raddad, L. J. ;
Chemaitelly, H. ;
Ayoub, H. H. ;
AlMukdad, S. ;
Yassine, H. M. ;
Al-Khatib, H. A. ;
Smatti, M. K. ;
Tang, P. ;
Hasan, M. R. ;
Coyle, P. ;
Al-Kanaani, Z. ;
Al-Kuwari, E. ;
Jeremijenko, A. ;
Kaleeckal, A. H. ;
Latif, A. N. ;
Shaik, R. M. ;
Abdul-Rahim, H. F. ;
Nasrallah, G. K. ;
Al-Kuwari, M. G. ;
Butt, A. A. ;
Al-Romaihi, H. E. ;
Al-Thani, M. H. ;
Al-Khal, A. ;
Bertollini, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (19) :1804-1816
[2]   Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants [J].
Abu-Raddad, Laith J. ;
Chemaitelly, Hiam ;
Butt, Adeel A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02) :187-189
[3]   Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients [J].
Amit, Sharon ;
Regev-Yochay, Gili ;
Afek, Arnon ;
Kreiss, Yitshak ;
Leshem, Eyal .
LANCET, 2021, 397 (10277) :875-877
[4]  
Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]
[5]   Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers [J].
Angel, Yoel ;
Spitzer, Avishay ;
Henig, Oryan ;
Saiag, Esther ;
Sprecher, Eli ;
Padova, Hagit ;
Ben-Ami, Ronen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (24) :2457-2465
[6]   Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant [J].
Bekliz, Meriem ;
Adea, Kenneth ;
Puhach, Olha ;
Perez-Rodriguez, Francisco ;
Melancia, Stefane Marques ;
Baggio, Stephanie ;
Corvaglia, Anna-Rita ;
Jacquerioz, Frederique ;
Alvarez, Catia ;
Essaidi-Laziosi, Manel ;
Escadafal, Camille ;
Kaiser, Laurent ;
Eckerle, Isabella .
MICROBIOLOGY SPECTRUM, 2022, 10 (04)
[7]   Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant [J].
Bernal, Jamie Lopez ;
Andrews, Nick ;
Gower, Charlotte ;
Gallagher, Eileen ;
Simmons, Ruth ;
Thelwall, Simon ;
Stowe, Julia ;
Tessier, Elise ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin E. ;
Hopkins, Susan ;
Chand, Meera ;
Ramsay, Mary .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) :585-594
[8]   BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort Study [J].
Bianchi, Francesco ;
Tafuri, Silvio ;
Migliore, Giovanni ;
Vimercati, Luigi ;
Martinelli, Andrea ;
Lobifaro, Annamaria ;
Diella, Giusy ;
Stefanizzi, Pasquale .
VACCINES, 2021, 9 (10)
[9]   Side effects among healthcare workers from a large Milan universityhospital after second dose ofBNT162b2 mRNA COVID-19 vaccine [J].
Borroni, Elisa ;
Consonni, Dario ;
Cugno, Massimo ;
Lombardi, Andrea ;
Mangioni, Davide ;
Bono, Patrizia ;
Oggioni, Massimo ;
Renteria, Sara Uceda ;
Bordini, Lorenzo ;
Nava, Carlo Domenico ;
Letzgus, Matteo ;
Silverj, Flaminia Gentiloni ;
Castaldi, Silvana ;
Rognoni, Magda ;
D'Oro, Luca Cavallieri ;
Carugno, Michele ;
Riboldi, Luciano ;
Ceriotti, Ferruccio ;
Bandera, Alessandra ;
Gori, Andrea ;
Pesatori, Angela Cecilia .
MEDICINA DEL LAVORO, 2021, 112 (06) :477-485
[10]  
Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO